Assessment of lncRNA GAS5, lncRNA HEIH, lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers: Recent insights into Egyptian patients with hepatitis C virus type 4

Table 3 Factors that discriminate between naïve patients (n = 30) and healthy controls (n = 20) using logistic regression analysis

Parameter	B	SE	P value	Odds ratio	Odds ratio (95%CI)
Univariate analysis
LncRNA-Gas5	1.95	0.675	0.004b	7.08	1.88-26.59
LncRNA-BISPR	1.2	0.421	0.004b	3.32	1.45-7.57
LncRNA-HEIH	-3.8	1.079	0.005b	0.02	0.003-0.184
mRNA BST2	-1.71	0.606	0.003b	0.17	0.05-0.587
ALT (IU/L)	0.2	0.06	0.001b	1.22	1.09-1.38
AST (IU/L)	0.42	0.135	0.002b	1.52	1.16-1.98
AFP (ng/ml)	0.358	0.165	0.03a	1.43	1.03-1.97
ALP (IU/L)	0.209	0.067	0.002b	1.23	1.080-1.4
Albumin (mg/dl)	-20.26	9.95	0.04a	0.01	0.00-0.471
Multiple analysis
LncRNA-Gas5	2.4	0.766	0.002b	11.12	2.47-49.88
mRNA-BST2	-2.71	1.013	0.007b	0.066	0.009-0.484

^aP < 0.05,

^bP < 0.01, indicates statistical significance.